Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Molecular Mechanisms Underlying Pluripotency and Self-Renewal of Embryonic Stem Cells.International journal of molecular sciences · 2023
   Pooled it
2. CRISPR-Cas9-Mediated Correction ofInternational journal of molecular sciences · 2023
   Article
3. Insights of CRISPR-Cas systems in stem cells: progress in regenerative medicine.Molecular biology reports · 2022
   Review
4. Current trends in gene recovery mediated by the CRISPR-Cas system.Experimental & molecular medicine · 2020
   Review
5. Derivation of trophoblast stem cells from naïve human pluripotent stem cells.eLife · 2020
   Article
6. [Research advances in transplantation for thalassemia major].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2020
   Review
7. Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) at naïve state.eLife · 2018
   Article
8. Inducible CRISPR genome editing platform in naive human embryonic stem cells reveals JARID2 function in self-renewal.Cell cycle (Georgetown, Tex.) · 2018
   Article
9. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.Stem cells translational medicine · 2018
   Article
10. CRISPR/Cas9-mediated genome editing in naïve human embryonic stem cells.Scientific reports · 2017
    Article
11. Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in β-Thalassemia-induced Pluripotent Stem Cells.The Journal of biological chemistry · 2016
    Article

Corrections and comments

• Erratum for
  Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.2016

Authors and funding

12 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.